Bio Ascend
Education for the science that matters most.
A Vaniam Group company. Founded 2012.
Bio Ascend is a medical education company built for the disease areas where the science is hardest and the stakes are highest — oncology, hematology, cell therapy, rare disease, metabolic disorders, immunology, and other pioneering areas of medicine.
Bio Ascend designs scientific education that meets clinicians where the science is moving — at key conferences, within academic and community settings, and through the questions shaping how today’s most complex therapeutic areas are practiced.
Built on scientific depth.
Every Bio Ascend program is grounded in the same standard: scientific rigor, clinical relevance, and respect for the time and expertise of the providers who participate.
That standard does not change based on accreditation status, therapeutic area, or program format; it is the foundation everything we deliver is built on.
CME programs
Bio Ascend’s accredited educational activities are developed in partnership with accredited CME providers — academic medical centers and independent accredited education companies — with each program designed, delivered, and evaluated in accordance with the standards of our accrediting partners.
Non-CME programs
Bio Ascend also develops nonaccredited scientific education for HCPs — programs designed to surface the questions, perspectives, and clinical considerations shaping practice in fields where the science is evolving fastest.
Trusted where the science is hardest.
Bio Ascend has spent 10 years in the conferences, the academic centers, and the conversations that define today’s oncology care paradigm and the most demanding therapeutic areas in medicine. Our team brings deep scientific expertise, our programs are built for clinicians who expect more, and our standard is the science itself.
Working with Bio Ascend.
Bio Ascend partners with biopharma medical affairs teams, foundations, academic institutions, and accredited education providers to develop and deliver scientific education across complex disease areas.
Bio Ascend is a wholly owned company of Vaniam Group. Bio Ascend operates as part of Vaniam Group, an integrated oncology organization built on 2 decades of scientific depth, trusted engagement, and longitudinal insight.
Learn more about how we improve patient outcomes.
